Article
Clinical and molecular spectrum of patients with 17β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiency.
Arquivos brasileiros de endocrinologia e metabologia - 1 Nov 2012
Castro Carla Cristina Telles de Sousa, Guaragna-Filho Guilherme, Calais Flavia Leme, Coeli Fernanda Borchers, Leal Ianik Rafaela Lima, Cavalcante-Junior Erisvaldo Ferreira, Monlleó Isabella Lopes, Pereira Silma Regina Ferreira, Silva Roberto Benedito de Paiva E, Gabiatti José Roberto Erbolato, Marques-de-Faria Antonia Paula, Maciel-Guerra Andrea Trevas, Mello Maricilda Palandi De, Guerra-Junior Gil
Abstract excerpt
The enzyme 17β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) catalyzes the conversion of androstenedione to testosterone in the testes, and its deficiency is a rare disorder of sex development in 46,XY individuals. It can lead to a wide range of phenotypic features, with variable hormonal profiles. We report four patients with the 46,XY karyotype and 17-β-HSD3 deficiency, showing different degrees of genital...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
